Forefrontpharma Co.,LTD

Shanghai Zhongqiang Pharmaceutical Co., Ltd. is a new biopharmaceutical company driven by R&D and innovation. In the early stage, the company will focus on the development of high-end generic drugs, while taking into account the R&D of innovative drugs. High-end generic drugs mainly include: difficult-to-synthesize generic drugs, first-copy and first-copy new drugs, semi-synthetic fermentation products, and special drug delivery systems such as rapid, slow and controlled release formulation technologies. Innovative drugs will include anti-cancer, anti-rheumatic, anti-viral and cardiovascular disease treatments. In order to support R&D projects, the company will introduce advanced analytical equipment and advanced formulation equipment to develop formulation products. In the next three years, the company will focus on the development of high-end generic drugs, strive to become a technological leader in the domestic industry and a similar enterprise with international competitiveness. In the medium and long term, the company will steadily enter the R&D of innovative drugs and grow into a new biopharmaceutical company with a complete product chain, sufficient funds, driven by innovation, and oriented to meet the needs of patients at home and abroad.